163 related articles for article (PubMed ID: 5281244)
1. Pulmonary lesions associated with busulfan therapy of chronic myelogenous leukemia.
Kirschner RH; Esterly JR
Cancer; 1971 May; 27(5):1074-80. PubMed ID: 5281244
[No Abstract] [Full Text] [Related]
2. Busulphan lung.
Woodliff HJ; Finlay-Jones LR
Med J Aust; 1972 Sep; 2(13):719-22. PubMed ID: 4507947
[No Abstract] [Full Text] [Related]
3. Busulphan lung.
Littler WA; Kay JM; Hasleton PS; Heath D
Thorax; 1969 Nov; 24(6):639-55. PubMed ID: 5260190
[TBL] [Abstract][Full Text] [Related]
4. [Fatal pulmonary fibrosis, with cellular lesions of the lung and pancreas, attributed to busulfan].
Batzenschlager A; Oberling F; Guerbaoui M; Vetter JM
Arch Anat Pathol (Paris); 1972 Sep; 20(3):291-4. PubMed ID: 4507846
[No Abstract] [Full Text] [Related]
5. Varied pulmonary lesions with intraalveolar large lamellar bodies in an autopsy case with busulfan therapy.
Miyashita T; Ojima A; Tuji T; Tajima T; Watanabe K
Acta Pathol Jpn; 1977 Mar; 27(2):239-49. PubMed ID: 266357
[TBL] [Abstract][Full Text] [Related]
6. Busulfan-induced pulmonary disease. Report of a case and review of the literature.
Burns WA; McFarland W; Matthews MJ
Am Rev Respir Dis; 1970 Mar; 101(3):408-13. PubMed ID: 5263678
[No Abstract] [Full Text] [Related]
7. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 40-1971.
Castleman B; McNeely BU
N Engl J Med; 1971 Oct; 285(15):847-55. PubMed ID: 5315205
[No Abstract] [Full Text] [Related]
8. Pulmonary ossification associated with long-term busulfan therapy in chronic myeloid leukemia. Case report.
Kuplic JB; Higley CS; Niewoehner DE
Am Rev Respir Dis; 1972 Nov; 106(5):759-62. PubMed ID: 4627906
[No Abstract] [Full Text] [Related]
9. Toxic manifestations of busulfan therapy.
Burns WA; McFarland W; Matthews MJ
Med Ann Dist Columbia; 1971 Sep; 40(9):567-72. PubMed ID: 5315525
[No Abstract] [Full Text] [Related]
10. Pulmonary toxicity recurring after a six week course of busulfan therapy and after subsequent therapy with uracil mustard.
Hankins DG; Sanders S; MacDonald FM; Drage CW
Chest; 1978 Mar; 73(3):415-6. PubMed ID: 272980
[TBL] [Abstract][Full Text] [Related]
11. Busulfan lung.
Pearl M
Am J Dis Child; 1977 Jun; 131(6):650-2. PubMed ID: 266839
[TBL] [Abstract][Full Text] [Related]
12. [The busulfan lung].
Pintos Fuentes RJ; Reissenweber N
Hoja Tisiol; 1970; 27(1):84-97. PubMed ID: 5291024
[No Abstract] [Full Text] [Related]
13. [Lung changes under busulfan therapy in a case of chronic myelosis].
Kolarz G; Pietsehmann H; Regele H
Zentralbl Allg Pathol; 1970; 113(5):539-44. PubMed ID: 5289458
[No Abstract] [Full Text] [Related]
14. Busulfan lung. Report of two cases and review of the literature.
Podoll LN; Winkler SS
Am J Roentgenol Radium Ther Nucl Med; 1974 Jan; 120(1):151-6. PubMed ID: 4520939
[No Abstract] [Full Text] [Related]
15. [Long-term results of busulfan treatment].
Comhaire F; Van der Straeten M; Van Hove W; Van Ganse W; Roels H
Acta Tuberc Pneumol Belg; 1970; 61(5):471-80. PubMed ID: 5281036
[No Abstract] [Full Text] [Related]
16. [Busulfan lung. Pulmonary fibrosis caused by Myleran].
Koch H; Lesch R
Med Welt; 1976 Feb; 27(7):308-11. PubMed ID: 1062649
[No Abstract] [Full Text] [Related]
17. Clinical and morphological side-effects of busulfan (Myleran) treatment.
Dahlgren S; Holm G; Svanborg N; Watz R
Acta Med Scand; 1972; 192(1-2):129-35. PubMed ID: 4506026
[No Abstract] [Full Text] [Related]
18. [Pulmonary fibrosis after busulfan therapy].
Jandl H; Franke A; Albrecht G
Z Gesamte Inn Med; 1975 Dec; 30(24):799-801. PubMed ID: 1062873
[TBL] [Abstract][Full Text] [Related]
19. Busulphan lung in childhood.
Oakhill A; Green ID; Knowlson GT; Cameron AH; Shah KJ; Hill FG; Mann JR
J Clin Pathol; 1981 May; 34(5):495-500. PubMed ID: 6941971
[TBL] [Abstract][Full Text] [Related]
20. Interstitial pulmonary fibrosis, atypical epithelial changes and bronchiolar cell carcinoma following busulfan therapy.
Min KW; Györkey F
Cancer; 1968 Nov; 22(5):1027-32. PubMed ID: 4301103
[No Abstract] [Full Text] [Related]
[Next] [New Search]
